Keyword Suggestion
Domain Informations
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 95.217.114.231
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
Site Inspections
Port Scanner (IP: 95.217.114.231)
Spam Check (IP: 95.217.114.231)
Email address with desentum.fi
Recent Searched Sites
› Muenchnerwerke.com (2 seconds ago) / CA
› Arieao98.svbtle.com (3 seconds ago) / US
› Thetemplebarpub.com (2 seconds ago) / NL
› Universalidadedabiblia.com.br (4 seconds ago) / US
› Shimuraskinclinic.jp (1 seconds ago) / US
› Huam.interpia98.net (1 seconds ago) / KR
› Qsjdsy.com (2 seconds ago) / ZA
› Supertekmodule.com (2 seconds ago) / US
› Dinaghmodesbridal.com (3 seconds ago) / GB
› Desentum.fi (1 seconds ago) / FI
› Cm-arganil.pt (1 seconds ago) / LT
› Borderlineagency.com (1 seconds ago) / KE
› Autodeore.com (4 seconds ago) / US
› Ankevanzuylen.com (1 seconds ago) / US
› Raldsandagate.com (1 seconds ago) / US
› Demingseniors.org (3 seconds ago) / US
› Syndicode.com (1 seconds ago) / US
› Thelastpatriotnews.com (2 seconds ago) / US
› Nlci38.getalma.com (1 seconds ago) / US
› Homecourtstringing.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with desentum.fi on Search Engine
Desentum
2021-05-17 · Kutsu Desentum Oy:n varsinaiseen yhtiökokoukseen / Summons to the Annual General Meeting of Desentum Oy 17.05.2021. Desentum Oy:n varsinainen yhtiökokous pidetään 25.5.2021 / The AGM of Desentum Oy is to be held on May 25th, 2021. Read more »
Desentum.fiSilja Halme - desentum.fi
FI Desentum. COMPANY. Board of Directors; Our Team; Desentum in the media ; EARTO Innovation Prize; Collaborations; HOW ALLERGIES WORK; PRODUCTS; MORE INFORMATION; Silja Halme Head of Quality & Regulatory Affairs, Desentum. Silja holds a M.Sc. degree in biochemistry from the University of Oulu. In her early career, she has worked …
Desentum.fiDesentum Company Profile | Management and Employees List
Desentum Profile and History . About Desentum Oy:Desentum is a biopharmaceutical company based in Helsinki, Finland. It is specialized in developing a novel type of allergen immunotherapy based on switching the immune system's response to allergens from hypersensitivity to tolerance by utilizing modified hypoallergens.
Datanyze.comDesentum raised 8 M€ to advance clinical development of ...
2022-01-21 · About Desentum Oy: Desentum is a biopharmaceutical company based in Espoo, Finland. It is specialized in developing a novel type of allergen immunotherapy based on switching the immune system's ...
Finance.yahoo.comDesentum - Home | Facebook
Desentum. May 14 ·. Siitepölyä. May 14. Koivun siitepölymäärät ovat maan etelä- ja keskiosissa pääosin erittäin runsaita. Siitepölyä voi kulkeutua myös pohjoisemmaksi, Etelä-Lappiin saakka. The pollen amounts of birch pollen are mostly very abundant in …
Facebook.comDesentum Oy
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing the hypoallergens used in immunotherapy. By studying the molecular mechanism of …
Finbio.netdesentum.fi | Desentum Oy - Fi-Domain.name
Desentum.fi Desentum Oy Runeberginkatu 49 A 22 00260 Helsinki FI Y-tunnus: 2425894-6 Puh: Lähde: Traficom. Siirry verkkotunnukseen . Verkkotunnus on ONLINE (ping: 346 ms) Desentum.fi on rekisteröity 8 vuotta sitten. Verkkotunnuksen haltija on Desentum Oy ja ...
Fi-domain.nameDESENTUM OY Email Format - desentum oy Employees Emails
DESENTUM OY's email format | General Email Format of people working for desentum oy. Email-verifier.io : the best email verifier in the world. Email-verifier.io . Back to homepage General email format of the people working at desentum oy Website of the company : desentum.com / Country : Finland / Industry : sign up to find out / Size of the company : sign …
Directory.email-verifier.ioDesentum (company) | Nordic 9
Desentum (company). Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing the hypoallergens used in immunotherapy. By studying the molecular …
Nordic9.comDesentum Company Profile - Office Locations, Competitors ...
2020-11-30 · Desentum has 5 employees across 2 locations. See insights on Desentum including office locations, competitors, revenue, financials, …
Craft.coDesentum DM-101-C-001 - lääketutkimus - Clinical Research ...
Sähköposti: [email protected] Puhelin arkisin (klo 12-15): 02 42064716 Yhteydenotto on luottamuksellinen eikä sido mihinkään. Tutkimuksen toteuttaa tutkimuspalveluyritys Clinical Research Services Turku – CRST Oy tutkimuskeskuksessaan Turussa (CRST Oy, Itäinen Pitkäkatu 4B, 20520 Turku). Tutkimuksen rahoittaa lääkekehitysyritys Desentum Oy. Otamme …
Crst.fiDesentum Oy Management | Desentum Oy Management Team
Desentum Oy employs 4 employees. The Desentum Oy management team includes Pekka Mattila (CEO), Anna Nilson (Head of Non-Clinical and Clinical Trials), and Kati Sallinen (Director, Strategy and Communications). Get Contact Info for All Departments
Rocketreach.coDesentum Oy - LinkedIn
Desentum Oy | 221 followers on LinkedIn. Imagine a world without allergies | Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for …
Fi.linkedin.comDesentum reports positive findings for the First-in-Human ...
2021-10-25 · Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, today announced positive First-in-Human clinical data of DM-101, its lead candidate for treatment of birch pollen allergy. DM-101 was found to be safe and well tolerated in a dose regimen of 5 ascending doses, and immunological marker results …
Ca.finance.yahoo.comDesentum Company Profile: Valuation & Investors - PitchBook
Desentum General Information Description. Developer of a biopharmaceutical platform designed to develop novel types of allergen immunotherapy products to fight allergies. The company's platform offers recombinant allergens which can be modified to suppress the histamine release during the desensitization process, enabling healthcare providers to significantly reduce the …
Pitchbook.comDesentum Oy - Detailed information - Largestcompanies
Desentum Oy - Research and experimental development on biotechnology. Nordic Market Data AB. Waterfront Building 3 SE-169 75 Solna
Largestcompanies.comDesentum - Desentum
Sijoita allergian voittamiseen! Joukkorahoitus käynnissä Lue lisää: http://www.desentum.fi/fi/yritys/joukkorahoitus-2017
Facebook.comDesentum Oy Employee Details, Technology Stack and More ...
Find useful insights on Desentum Oy’s employee, technology stack, location, news alerts and more at Slintel. Use Slintel to connect with top decision-makers at Desentum Oy.
Slintel.comRaisedToday.com
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made …
Raisedtoday.comDesentum Oy - Overview, Competitors, and Employees | Apollo.io
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries …
Apollo.io
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| soniapittet.com | publicdomainregistry.com | -3 Years, -252 Days |
| premierobgyn-fl.com | fastdomain.com | -4 Years, -2 Days |
| livemidtownapts.com | godaddy.com | -4 Years, -116 Days |
| getproxylist.com | tucows.com | -4 Years, -232 Days |
| xiaomiru.org | namecheap.com | -4 Years, -196 Days |
| workloft.in | godaddy.com | -4 Years, -51 Days |
| buffervalley.com | godaddy.com | -3 Years, -307 Days |
| hix05.com | gmo.jp | -4 Years, -153 Days |
| gruenwristwatches.com | ionos.com | -4 Years, -165 Days |
| 205warren.net | namecheap.com | 239 Days |